Menu Envision Pharma Group has successfully renewed its certification to International Standard Organization (ISO)/IEC 27001. Along with completing the ISO re-certification audits, new office locations have been included in addition – so the expanded coverage now comprises Hammersmith, Horsham, Marlow and Wilmslow in the UK; Glastonbury, Madison, Philadelphia, Southport and Stirling in the US; and Sydney in Australia. ISO 27001 is an internationally recognised information security standard that is certified by an independent certification body, and demonstrates a commitment to prospective and existing clients that their sensitive data is protected and in compliance with pertinent security and privacy regulatory requirements – such as Privacy Shield and GDPR. Kevin Wheatley, Global Head, Facility and Operations at Envision, commented, “We are delighted to announce we have passed again with a completely clean sweep. This achievement demonstrates Envision’s commitment to information governance and the safeguarding of our clients’ data. A big thank you goes to everyone involved in the process.” ISO develops standards that are accepted as pre-eminent in over 140 countries, including the USA, Australia, Japan and the UK. These standards facilitate international exchange of goods and services, support sustainable and equitable economic growth, promote innovation and protect health, safety and the environment. By attaining this certification, Envision has demonstrated a clear commitment to Information Security Management to third-parties and stakeholders, facilitating a process and framework to ensure the fulfilment of commercial, contractual and legal responsibilities, and providing for a common security approach within the Envision business units and a formal basis for interoperability between Envision and its customers. Dot grid. Related news View all news Our growing presence in Japan and the Asia-Pacific region News/events Our growing presence in Japan and the Asia-Pacific region August 30, 2017 Envision Pharma Group wins “Best Original Research” prize at ISMPP for the second year running News/events Envision Pharma Group wins “Best Original Research” prize at ISMPP for the second year running August 26, 2017 Envision Pharma Group announces the availability of Scopus citation counts in Datavision News/events Envision Pharma Group announces the availability of Scopus citation counts in Datavision April 24, 2017 Envision announces Altmetric attention data now available in Library™ scientific content management software News/events Envision announces Altmetric attention data now available in Library™ scientific content management software April 24, 2017 Envision Pharma Group launches Medinfo™ – a new purpose-built software solution for medical information News/events Envision Pharma Group launches Medinfo™ – a new purpose-built software solution for medical information March 20, 2017 iEnvision Contact us ISO/IEC 27001 Certification Twitter LinkedIn © 2001-2020 Envision Pharma Group. All rights reserved. Terms of use Privacy notice Cookies notice Privacy shield policy Modern slavery statement We use cookies on our website. By continuing to use this website, you consent to our use of cookies in accordance with our cookie policy. To learn more about cookies, how we use them, and how you can change your settings, please view our Cookies Notice Accept